Postpartum Visit Timing and the Effect on Visit Attendance
NCT ID: NCT05399784
Last Updated: 2023-08-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
162 participants
INTERVENTIONAL
2021-02-01
2023-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Shortened Time Interval to Postpartum Visit in Improving Postpartum Attendance
NCT03165838
Prevention of Postpartum Depression in Low-Income Women
NCT00053651
Postpartum Care Timing: A Randomized Trial
NCT03733405
The Effects of Pregnancy Classes and Contributing Factors to Postpartum Depression
NCT03763435
Behavioral Change in the Mother-Infant Dyad: Preventing Postpartum Depression
NCT01379781
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The long term goal of our program is to improve postpartum care for women in Rhode Island. The primary objective of this project is to determine if the ACOG proposed additional postpartum visit within three weeks of delivery improves attendance to postpartum appointments compared to routine postpartum care. Additionally, we intend to examine whether having two scheduled postpartum visits (one within three weeks and the other at the standard 4-6 week postpartum time point) which we describe as "early and often" postpartum care-improves patient knowledge, satisfaction and trust in clinicians compared to routine care as well as explore patient preferences for postpartum care. Our central hypothesis is that early and often postpartum care will lead to improved patient visit attendance compared to routine care.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early & Often Postpartum Care
Visit at 2-3 and 6 weeks postpartum.
Early postpartum visit
The early postpartum visit will be an in-person visit with a medical provider at 14-21 days postpartum.
Standard postpartum visit
The standard postpartum visit will occur at 35 to 56 days postpartum.
Standard Postpartum Care
Visit at 6 weeks postpartum.
Standard postpartum visit
The standard postpartum visit will occur at 35 to 56 days postpartum.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Early postpartum visit
The early postpartum visit will be an in-person visit with a medical provider at 14-21 days postpartum.
Standard postpartum visit
The standard postpartum visit will occur at 35 to 56 days postpartum.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* literacy in English or Spanish
* receipt of prenatal care at the Obstetrics and Gynecology Care Center of Women \& Infants Hospital
* delivery at Women \& Infants Hospital during the study time period
Exclusion Criteria
* chronic hypertension
* gestational hypertension
* preeclampsia
* eclampsia
* third degree perineal laceration
* fourth degree perineal laceration
* blood product transfusion
* intensive care unit admission
* who were prescribed anxiolytic or antidepressant medications in the antepartum period
13 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Women and Infants Hospital of Rhode Island
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martha B Kole-White, MD
Role: PRINCIPAL_INVESTIGATOR
Women & Infants Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Women & Infants Hospital
Providence, Rhode Island, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Kole_ConstanceHowesGrant_2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.